Key Takeaways
- • China's secondary private equity market surged 89% in the first half of 2025, with yuan-denominated deals reaching a record 77.3 billion yuan ($11 billion), signaling robust institutional investor appetite for alternative exposure in the region.
- • Global investors increasingly view China's secondary PE market as an "excellent way to get risk-adjusted exposure to Asia," particularly as traditional exit routes through IPOs face headwinds and early-stage investors seek liquidity through secondary fund sales.
- • The LP-led secondaries marketplace in China has demonstrated consistent growth since 2017, with recent momentum driven by improved investor sentiment toward Chinese equities following regulatory support and bottom-up company re-evaluation sparked by AI innovation (DeepSeek) and policy signals from Beijing.
- • China's secondary PE market expansion reflects broader market recovery dynamics: late 2024 saw government stimulus announcements, while 2025 gains are anchored in fundamental company valuations and supportive government policies announced at the March Two Sessions focused on consumer spending and real estate stabilization.
- • Major institutional investors, including the A$170 billion Aware Super, are repositioning China exposure as strategically essential despite persistent macroeconomic concerns around consumer demand, with notable inflows returning to Chinese assets and away from emerging markets ex-China products.
Summary
China's secondary private equity market is experiencing significant momentum, with the yuan-denominated secondaries sector recording an 89% surge in the first half of 2025 and reaching a record 77.3 billion yuan ($11 billion) in deal value. This expansion reflects a fundamental shift in global investor positioning toward China's alternative investment landscape, as institutional capital increasingly recognizes the secondaries market as a strategic vehicle for obtaining risk-adjusted exposure to Asian assets.
The growth trajectory of China's LP-led secondaries marketplace has been consistent since 2017, but recent acceleration coincides with a broader recovery in investor sentiment toward Chinese equities. According to institutional sources, the market recovery follows two distinct phases: late 2024 was characterized by top-down stimulus policy announcements from Beijing, while 2025 gains are anchored in bottom-up factors as investors reassess Chinese company fundamentals. A notable catalyst has been the breakthrough AI developments from DeepSeek, which prompted renewed analytical focus on Chinese technology and innovation capabilities.
Government policy support has reinforced market confidence. In February 2025, Chinese President Xi Jinping convened meetings with major business leaders, including Alibaba's Jack Ma—a symbolic gesture signaling improved government-private sector relations. Subsequently, the nation's Two Sessions in March introduced supportive economic policies targeting consumer spending increases and stabilization of vulnerable sectors including real estate and local government debt. This dual dynamic—government policy support combined with fundamental company re-evaluation—has created momentum for expanded investor participation.
For global institutional investors, the secondary market structure addresses critical liquidity challenges in China's private equity ecosystem. Beyond traditional IPO exit routes, early-stage fund investors can now liquidate positions by selling shares to later-stage funds, improving overall portfolio flexibility. Major institutional players such as Aware Super (A$170 billion in AUM) have repositioned China as a non-negotiable component of global diversified portfolios despite acknowledging persistent macroeconomic headwinds including weak consumer demand. This positioning reflects recognition that China's scale and market significance preclude meaningful underweighting in institutional allocations.
Inflows have notably shifted away from emerging markets ex-China products and back toward direct Chinese exposure, including American Depositary Receipts (ADRs) listed in the United States. The secondary market's expansion therefore represents both tactical redeployment of existing China commitments and strategic repositioning of asset allocation frameworks among sophisticated institutional investors reassessing risk-adjusted return opportunities in the region.
The growth trajectory of China's LP-led secondaries marketplace has been consistent since 2017, but recent acceleration coincides with a broader recovery in investor sentiment toward Chinese equities. According to institutional sources, the market recovery follows two distinct phases: late 2024 was characterized by top-down stimulus policy announcements from Beijing, while 2025 gains are anchored in bottom-up factors as investors reassess Chinese company fundamentals. A notable catalyst has been the breakthrough AI developments from DeepSeek, which prompted renewed analytical focus on Chinese technology and innovation capabilities.
Government policy support has reinforced market confidence. In February 2025, Chinese President Xi Jinping convened meetings with major business leaders, including Alibaba's Jack Ma—a symbolic gesture signaling improved government-private sector relations. Subsequently, the nation's Two Sessions in March introduced supportive economic policies targeting consumer spending increases and stabilization of vulnerable sectors including real estate and local government debt. This dual dynamic—government policy support combined with fundamental company re-evaluation—has created momentum for expanded investor participation.
For global institutional investors, the secondary market structure addresses critical liquidity challenges in China's private equity ecosystem. Beyond traditional IPO exit routes, early-stage fund investors can now liquidate positions by selling shares to later-stage funds, improving overall portfolio flexibility. Major institutional players such as Aware Super (A$170 billion in AUM) have repositioned China as a non-negotiable component of global diversified portfolios despite acknowledging persistent macroeconomic headwinds including weak consumer demand. This positioning reflects recognition that China's scale and market significance preclude meaningful underweighting in institutional allocations.
Inflows have notably shifted away from emerging markets ex-China products and back toward direct Chinese exposure, including American Depositary Receipts (ADRs) listed in the United States. The secondary market's expansion therefore represents both tactical redeployment of existing China commitments and strategic repositioning of asset allocation frameworks among sophisticated institutional investors reassessing risk-adjusted return opportunities in the region.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.